NP47822 Multiple Sclerosis Medicines
The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS")
This tender has closed
The submission deadline for this contract has passed. There may be more active supplies tenders from The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS"), and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS") awarded this contract to Biogen Idec Ltd | Merck Serono Limited | Mylan | Teva UK Limited worth £12,985,684 on 17 Jan 2023.
Description
Supply of Multiple Sclerosis Medicines to NHS Scotland
Full description
Supply of Multiple Sclerosis Medicines to NHS Scotland. The Authority has awarded the Framework Agreement as a multi supplier framework agreement per line to four (4) Framework Participants.
The medicines awarded to the Framework Agreement are as follows:
- Glatiramer acetate injection
- Interferon beta-1a
Additional information
The estimated values referred to in Section II.1.5 and 11.2.6 covers the twenty-six (26) months' contract duration and the twenty-two (22) months' extension period of the Framework Agreement.
For further details of individual lines for the Products awarded to the Framework Agreement, please contact the named person at the head of this Notice.
Awarded suppliers (4)
- Biogen Idec Ltd
- Merck Serono Limited
- Mylan
- Teva UK Limited
Contact
Identifiers
Explore related tenders
External ID: pcs-ocds-r6ebe6-0000721538 • Added 27 May 2026